Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

HUI YING HOU

Allopathic & Osteopathic Physicians Obstetrics & Gynecology

NPI
1184911687
CMS profile
2078666
Location
JERSEY CITY, NJ

General Payments · PY2019–2025

$5,512.71

  • Reported across 174 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$219.20

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $219.20 13

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Astellas Pharma US Inc $39.24 2
MAYNE PHARMA COMMERCIAL LLC $38.54 3
Exeltis, USA Inc. $36.73 2
MILLICENT US INC $34.99 2
DEXCOM, INC. $25.40 1
Sumitomo Pharma America, Inc. $19.04 1
Evofem Biosciences, Inc. $16.99 1
Organon LLC $8.27 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $392.85 22
PY2020 $143.09 10
PY2021 $407.25 28
PY2022 $805.87 57
PY2023 $3,302.34 31
PY2024 $242.11 13
PY2025 $219.20 13

Payment records · PY2025 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $18.20 05/01/2025 Food and Beverage Undisputed 06/30/2026 1238787151 CMS
Astellas Pharma US Inc $21.04 11/25/2025 Food and Beverage Undisputed 06/30/2026 1238570413 CMS
Dexcom, Inc. $25.40 10/15/2025 Food and Beverage Undisputed 06/30/2026 1250489660 CMS
Evofem Biosciences, Inc. $16.99 07/09/2025 Food and Beverage Undisputed 06/30/2026 1253956423 CMS
Exeltis, USA Inc. $19.73 04/02/2025 Food and Beverage Undisputed 06/30/2026 1218195443 CMS
Exeltis, USA Inc. $17.00 12/08/2025 Food and Beverage Undisputed 06/30/2026 1218195445 CMS
MAYNE PHARMA COMMERCIAL LLC $18.05 02/06/2025 Food and Beverage Undisputed 06/30/2026 1254330232 CMS
MAYNE PHARMA COMMERCIAL LLC $16.99 02/14/2025 Food and Beverage Undisputed 06/30/2026 1254330146 CMS
MAYNE PHARMA COMMERCIAL LLC $3.50 11/05/2025 Food and Beverage Undisputed 06/30/2026 1254334694 CMS
MILLICENT US INC $17.45 05/22/2025 Food and Beverage Undisputed 06/30/2026 1235197437 CMS
MILLICENT US INC $17.54 07/11/2025 Food and Beverage Undisputed 06/30/2026 1235197439 CMS
Organon LLC $8.27 06/26/2025 Food and Beverage Undisputed 06/30/2026 1237668562 CMS
Sumitomo Pharma America, Inc. $19.04 07/24/2025 Food and Beverage Undisputed 06/30/2026 1176667899 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.